Jamshidi Khodamorad, Haji Agha Bozorgi Milad, Mokhtari Ehsan, Bagherifard Abolfazl, Mirzaei Alireza
Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Indian J Orthop. 2023 Jan 13;57(3):453-460. doi: 10.1007/s43465-022-00813-2. eCollection 2023 Mar.
Osteosarcoma of the scapula is extremely rare. Hence, there is no consensus regarding its optimal management. In this study, we report the demographics, characteristic features, and outcomes of scapulectomy with or without scapular allograft reconstruction in a series of patients with primary scapular osteosarcoma.
Twelve patients with primary scapular osteosarcoma who were treated by scapulectomy with or without scapular allograft reconstruction (five and seven patients, respectively) were included. The allograft was fixed in place using a dacron tape without a plate or screw. The function of the shoulder was evaluated using the Musculoskeletal Tumor Society (MSTS) score for the upper extremity and Toronto Extremity Salvage Score (TESS).
The study population included seven (58.3%) males and five (41.7%) females with a mean age of 30 ± 8.2 years. The histologic type of the tumor was osteoblastic in the majority of patients ( = 8, 66.7%). At an average follow-up of 6.5 ± 2.3 years, only one local recurrence (8.3%) occurred in our patients that coincided with lung metastasis. The mean MSTS score was 78.7 ± 3.8% and 66.2 ± 4% in patients with and without scapular allograft, respectively ( = 0.006). The mean TESS was 78.6 ± 5.6 and 68.4 ± 2.4 in patients with and without scapular allograft, respectively ( = 0.005). The overall 5-year survival of the patients was 85.7%.
Osteosarcoma of scapula more frequently occurs in the fourth decade of life, mainly presented with a sclerotic radiologic appearance. Patients with scapular allograft impaction after scapulectomy have better functional outcomes compared to those without boney reconstruction.
肩胛骨骨肉瘤极为罕见。因此,对于其最佳治疗方案尚无共识。在本研究中,我们报告了一系列原发性肩胛骨骨肉瘤患者行肩胛骨切除并伴有或不伴有肩胛骨同种异体骨移植重建的人口统计学、特征及结果。
纳入12例接受了肩胛骨切除并伴有或不伴有肩胛骨同种异体骨移植重建(分别为5例和7例)的原发性肩胛骨骨肉瘤患者。同种异体骨使用涤纶带固定在位,未使用钢板或螺钉。使用肌肉骨骼肿瘤学会(MSTS)上肢评分和多伦多肢体挽救评分(TESS)评估肩部功能。
研究人群包括7例(58.3%)男性和5例(41.7%)女性,平均年龄为30±8.2岁。大多数患者(n = 8,66.7%)肿瘤的组织学类型为成骨细胞型。平均随访6.5±2.3年,我们的患者中仅发生1例局部复发(8.3%),且与肺转移同时发生。有肩胛骨同种异体骨移植和无肩胛骨同种异体骨移植的患者的平均MSTS评分分别为78.7±3.8%和66.2±4%(P = 0.006)。有肩胛骨同种异体骨移植和无肩胛骨同种异体骨移植的患者的平均TESS分别为78.6±5.6和68.4±2.4(P = 0.005)。患者的总体5年生存率为85.7%。
肩胛骨骨肉瘤更常见于生命的第四个十年,主要表现为硬化的影像学表现。与未进行骨重建的患者相比,肩胛骨切除术后进行肩胛骨同种异体骨植入的患者功能结局更好。